The differential diagnosis of AMKL mainly lies in histopathology, encompassing MDS 5q-, RARST (now MDS/MPN with SF3B1 mutation and thrombocytosis), panmyelofibrosis, and myeloproliferative tumors (including evolving cases). This evidence concerns the gene SF3B1 and acute megakaryoblastic leukemia.